The NHS in England is embarking on a groundbreaking initiative to provide tens of thousands of children and adults living with type 1 diabetes with an ‘artificial pancreas’. This innovative device continuously monitors blood glucose levels and adjusts insulin delivery automatically, potentially transforming the lives of those with the condition. The rollout follows a successful pilot and is supported by £2.5 million in funding from NHS England. NICE approved the technology in December 2023, and a 5-year implementation strategy outlines eligibility criteria and timelines. The initiative aims to ease the burden on patients, improve outcomes, and simplify diabetes management. Patients who have already benefited from the artificial pancreas praise its transformative impact on their daily lives. The rollout has been welcomed by health experts and advocacy groups, who emphasise its potential to improve health and quality of life for people with type 1 diabetes.
https://www.england.nhs.uk/2024/04/nhs-rolls-out-artificial-pancreas-in-world-first-move